LINJARDY MXR 12.5/2.5/1000MG TAB

LINJARDY MXR is a combination tablet containing empagliflozin, linagliptin, and metformin. This triple-action formulation is designed to help manage type 2 diabetes by improving blood sugar control through multiple mechanisms. Empagliflozin works by increasing glucose excretion, linagliptin enhances insulin secretion, and metformin reduces glucose production. Each tablet contains 12.5mg empagliflozin, 2.5mg linagliptin, and 1000mg metformin. Suitable for patients requiring comprehensive glycemic management. Always use as directed by your healthcare provider.